BACKGROUND: In @entity1 with @entity259 ( @entity259 ), lung and bone @entity3 sometimes occur. However, brain @entity3 (BM) is extremely rare. Because most previous reports about BM from @entity259 included a relatively small number of cases, the clinical characteristics and outcomes of BM are still unclear. @entity1 AND METHODS: Between 1965 and 2013, among 961 @entity1 who had died because of @entity259 , 24 @entity1 were diagnosed with BM from @entity259 . One @entity1 with BM from @entity259 is still alive. To identify the prognostic factors for longer survival after BM, the medical records of these 25 @entity1 were retrospectively reviewed. RESULTS: The median age at BM diagnosis was 66  years. Typical symptoms associated with BM had appeared in 20 @entity1 (80  %). The Karnofsky Performance Status (KPS) was good (>= 70) in 10 @entity1 and poor ( <=60) in 15 @entity1 . Seven @entity1 had a single intracranial lesion of BM, 6 @entity1 had 2 or 3 lesions, and 9 @entity1 had 4 or more. Eleven @entity1 did not receive any treatment for BM, and 14 @entity1 underwent surgical resection, radiation therapy, or both. One-year and 5-year disease-specific survival rates were 28 and 10.6  %, respectively. Good KPS (>= 70), small number of @entity1504 ( <=3), and treatment for BM were prognostic factors for long survival on univariate analysis (p  <  0.05). On multivariate analysis, only treatment for BM was significant. CONCLUSION: Treatment of BM from @entity259 is indicated in @entity1 who have a good KPS and fewer @entity1504 , and some of them may achieve long survival.

Prognosis After Brain Metastasis from Differentiated XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity259 :: ('MESH:D013964', 'Disease') :: ['DTC', 'differentiated thyroid carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity1504 :: ('MESH:D002561', 'Disease') :: ['intracranial lesions']
@entity259 :: (MESH:D013964,Disease) :: ['Thyroid Carcinoma']
